Contribution to antimicrobial profile investigation of phenylcarbamic acid derivatives containing substituted N-phenylpiperazine fragment
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62157124%3A16370%2F12%3A43871063" target="_blank" >RIV/62157124:16370/12:43871063 - isvavai.cz</a>
Výsledek na webu
—
DOI - Digital Object Identifier
—
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Contribution to antimicrobial profile investigation of phenylcarbamic acid derivatives containing substituted N-phenylpiperazine fragment
Popis výsledku v původním jazyce
The set of new original, higly lipophilic basic esters of phenylcarbamic acid containing 4-(2-fluoro-/4-fluorophenyl)piperazin-1-yl moiety, labelled as 1-12, was screened for in vitro antimicrobial activity against Escherichia coli, Candida albicans andStaphylococcus aureus, respectively. Following the minimum inhibitory concentration (MIC) assay by microdilution method, all tested molecules were against S. aureus, E. coli as well as C. albicans practically inactive. The study has revealed that the position of carbamate group have appeared to be the most notable factor which decisively influence the activity of tested compounds in the comparison with the importance of electronic or hydrophobic interactions induced by the substitution at the N-phenylpiperazine ring. Additionally, the lipophilicity rising had been regarded as relevant but not ultimate aspect for the effectiveness of these molecules. Finally it can be concluded that mandatory requirement for the activity maintenance agai
Název v anglickém jazyce
Contribution to antimicrobial profile investigation of phenylcarbamic acid derivatives containing substituted N-phenylpiperazine fragment
Popis výsledku anglicky
The set of new original, higly lipophilic basic esters of phenylcarbamic acid containing 4-(2-fluoro-/4-fluorophenyl)piperazin-1-yl moiety, labelled as 1-12, was screened for in vitro antimicrobial activity against Escherichia coli, Candida albicans andStaphylococcus aureus, respectively. Following the minimum inhibitory concentration (MIC) assay by microdilution method, all tested molecules were against S. aureus, E. coli as well as C. albicans practically inactive. The study has revealed that the position of carbamate group have appeared to be the most notable factor which decisively influence the activity of tested compounds in the comparison with the importance of electronic or hydrophobic interactions induced by the substitution at the N-phenylpiperazine ring. Additionally, the lipophilicity rising had been regarded as relevant but not ultimate aspect for the effectiveness of these molecules. Finally it can be concluded that mandatory requirement for the activity maintenance agai
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FR - Farmakologie a lékárnická chemie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Ostatní
Rok uplatnění
2012
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
International Journal of Biological and Medical Research
ISSN
0976-6685
e-ISSN
—
Svazek periodika
3
Číslo periodika v rámci svazku
4
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
4
Strana od-do
2531-2534
Kód UT WoS článku
—
EID výsledku v databázi Scopus
—